Open Access Online Scientific Journal

Research Article

J Med Discov (2017); 2(1):jmd17005; doi:10.24262/jmd.2.1.17005; 
Received March 20th, 2017, Accepted March 24th, 2017, Published March 27th, 2017.

Importance of Local Therapy with the Use of A New Hygienical Agent in Combination Therapy of Patients with Diseases of Oral Mucosa

L. S. Kravchenko1,*, V. V. Babienko1, M. V. Rozumenko1

1The Odessa National Medical University, Odessa, Ukraine

* Correspondence: Lyudmila Kravchenko, The Odessa National Medical University, Odessa, Ukraine. Email: lyudmila.kravchenko.52@mail.ru

Abstract

On the base of clinical observations and biochemical study of oral fluid in patients with diseases of oral mucous membrane the efficiency of use the hygienic agent – apigel is proved by decrease of the level of the markers of inflammation (protein and protease), bacterial insemination (urease), inhibition of free-radical oxidation and the degree of dysbiosis, stimulate lysozyme secretion and activity of antioxidant system (catalase, SOD), has positive influence on nonspecific resistance in oral cavity in comparison with a standard therapy.

Keywords: oral liquid, inflammation, disbiosis, enzymes, lysozyme

Introduction

The diseases of oral mucosa (OM), which take place under the action of etiologic factors, both exogenous and endogenous, have great value in practice of dentist. In spite of progress in modern dentistry today, prevention and treatment of OM diseases is a problem.

The combination therapy of OM diseases uses influence on the pathogenetic links of pathological process for renewal of structural and functional elements of mucous membrane and removal of local irritants by the use of local therapy, professional hygiene. State of factors of nonspecific and specific protection plays the main part in administered therapy. As a result it is necessary to use local therapy with application of oral care hygienic means, which allows as effective as possible to provide capacity of tissues to protect from infection and regeneration.

The purpose of this work is evaluation of efficiency of local application of developed oral care gel in the combination therapy of the OM diseases.

Materials and Methods

C42 persons (15–30 years old) had complex dental exam, and were divided into 3 groups. The basic group and group of comparison included 27 patients with the OM diseases. The diagnosis was established on the basis of objective examination, anamnesis, clinical, clinical and laboratory and biochemical examinations. In order to obtain objective results all examined patients in these groups were comparable by age, sex, disease course and level of injury. 15 patients had mechanical trauma of OM (8 patients with the chronic traumatic erythema, 7 – with the chronic traumatic erosion), 12 patients had toxic stomatitis as a result of mechanical, chemical-toxic irritation while using removable denture. The basic group included 14 patients, who were treated with local application of a new hygienic agent in the combination therapy – the gel on the basis of apiproducts and other biologically active matters [1] as applications, layer thickness 0.5-0.8 mm 2–3 times per a day during 5–7 days (depending on type and severity of inflammatory process). The group of comparison consisted of 13 patients with OM, which had a standard therapy, without application of gel. The group of control consisted of 15 persons of the same age without dental pathology. All examined patients had no serious concomitant diseases.

Efficiency of treatment was evaluated taking into account the common condition of patients, clinical and laboratory data. Therapy was evaluated by the next parameters: level of oral hygiene by dynamics of OHI-S (oral hygiene index); presence of inflammatory process by PMA index; bleeding by PBI (papilla bleeding index) Muhlemann-Saxer index; pain severity by the visual-analog ten-point scale [2]. In the oral fluid sampled in fasting state [3] there was determined protein level by O.H. Lowory et al., total proteolytic activity (TPA) [4], malonic dialdehyde (MDA) concentration by tiobarbituric method [5], urease activity and dysbiosis level in oral cavity by fermentation method [6], activity of antioxidant defence by catalase (К) [7] and superoxide dismutase (SOD) activity [8] antioxidant-prooxidant index (API) in relation of K to MDA, lysozyme activity by bacteriologic technique [9].

 

Statistical analysis

The statistical analysis of obtained data was conducted with Student’s t-test. A p-value less than 0.05 was considered significant.

Results

As a result of dental examination all patients were revealed clinical signs of the inflammatory diseases of OM. Clinical examination detected that all persons with injured OM had change in color of oral mucosa (hyperemia of different intensity – from slight reddening to bright red coloration). These changes were accompanied by edema in 25%, by burning and dry mouth in 50%; 3 (11.1%) patients had increase in Candida fungi. The application of apigel in the combination therapy of patients with the OM diseases improved basic clinical symptoms.

Gel applications with professional hygiene improved the oral hygiene level dramatically (Table 1). So, oral hygiene index decreased from 2.56±0.14 to 0.15±0.03, i.e. 17 times after the administered treatment. In case of a standard therapy there was a rise of oral hygiene index: the index of hygiene decreased from 2.42±0.16 to 0.53±0.05 after the treatment, i.e. only 4.5 times.

The application of apigel resulted in reduction of gingival bleeding on average from 2.92±0.09 to 0.76±0.04, in the group of comparison decrease is less pronounced — on average from 2.74±0.11 to 1.25±0.14.

Table 1. Dynamics of clinical signs of oral cavity in patients at the background of administered therapy
Data Groups of patients
Control group Basic group Group of comparison
Before treatment After
treatment
Before treatment After treatment
Oral
hygiene index ОНI-S

Р

Р1

0.12±0.03 2.56±0.14

<0.05

0.15±0.03

>0.05
<0.05

2.46±0.16

<0.05

0.53±0.05

<0.05
<0.05

РМА

Р

Р1

2.40±1.04 45.30±2.4
<0.05
3.10±1.31
>0.05
<0.05
43.25±1.65
<0.05
9.10±1.28
<0.05
<0.05
Bleeding index РВI

Р

Р1

0.64±0.06 2.92±0.09

<0.05

 

0.76±0.04

>0.05

<0.05

2.74±0.11

<0.05

1.25±0.14

<0.05

<0.05

Evaluation of pain severity by
10-point score

Р

Р1

0 7.10±0.20

<0.05

 

1.68±0.11

<0.05

<0.05

6.40±0.28

<0.05

 

3.30±0.18

<0.05

<0.05

Note: P — statistical significance with the control group; P1 — statistical significance with group “before treatment”.

Stable subsided inflammation was confirmed by positive dynamics of PMA index in both groups of the OM patients, the more intensive anti-inflammatory reaction was observed in the basic group. By the end of treatment the PMA index in patients with common therapy fell down from 43.25±1.65 to 9.10±1.28, while in basic group of patients — from 45.3±2.4 to 3.10±1.31.

As the inflammatory diseases of OM are accompanied by pain, great attention was attached to the analysis of anaesthetic effect of the new hygienic agent. Pain severity in patients of the basic group on 3rd–5th day of apigel applications decreased on average from 7.10±0.20 to 1.68±0.11. The patients of comparison group had pain relief from 6.40±0.28 to 3.30±0.18, remaining at the same level up to 7th day of treatment.

The pronounced improvement of clinical symptoms in patients with the OM diseases in case of apigel applications is conditioned by its anti-inflammatory and anesthetic properties.

The conducted biochemical analysis of oral fluid in patients with the OM diseases revealed the increase of inflammation markers – TPA and MDA (1.6 and 2.2 times correspondingly). The local application of apigel in the combination therapy of these patients allowed to lower the TPA level in 7 days, level of protein and MDA came to the norm. The table 2 demonstrates that the comparison group patients had higher indices which did not reach the norm.

Along with intensification of lipid peroxidation and inflammation in the oral cavity in case of the OM diseases there was a great rise in conditioned pathogenic and pathogenic bacterial flora, which is confirmed by growing activity of urease in the oral fluid. The level of this enzyme in the oral fluid of patients increased 3 times as much. Urease activity in patients who were administered standard therapy was at the definite high level as compared with the control group and exceeded the corresponding values in the basic group. During treatment in the basic group of patients the activity of urease fell down by 38%, in the group of comparison only by 22%, 3 times decrease of oral disbiosis level in the patients of the basic group, 1,6 times in the group of comparison, which proves antimicrobial local action of the new gel.

Growth of pathogenic bacterial flora in the oral cavity is connected with decrease of lysozyme activity in case of the OM diseases. Prescription of gel for patients of the basic group contributed to rise of lysozyme activity up to the normal level, while it was only a tendency to rise in the group of comparison.

Analysis of oral fluid in patients with the OM diseases revealed significant decrease of basic enzymes activity of antioxidant defense: catalase on average by 66.6% and SOD – by 64%, correspondingly the antioxidant-prooxidant index decreased too. The local application of apigel, lowering inflammatory phenomena, activated AOS protective enzymes in the oral fluid. Level of K and SOD activity in patients of the basic group rose by the end of treatment up to the norm, which proves antioxidant properties of the new gel. The activity of given enzymes had a less pronounce dynamics in the group of comparison.

So, the conducted examination revealed positive action of local application of the new oral care agent in the combination therapy of the OM diseases on the dynamics of clinical symptoms due to its anti-inflammatory and anesthetic properties. Biochemical analysis of oral fluid in patients with the OM diseases showed that the use of apigel prevents from growth of pathogenic bacterial flora, and rise in inflammation and lipid peroxidation, stimulates activity of lysozyme and enzymes of the antioxidant system, which improves nonspecific resistance in the oral cavity.

Table 2. Influence of combination therapy on the biochemical indexes of oral fluid in patients with traumatic injuries of oral mucosa
Indices Patients with OM diseases
Control
(norm)
p=15
Basic group Group of comparison
Before treatment After treatment Before treatment After treatment
TPA,
ncat/l
P
P1
1.74±0.20 2.87±0.38

<0.05

1.82±0.28

>0.05
<0.05

2.99±0.40

<0.05

2.27±0.46

>0.05
>0.05

Level of protein, g/l
P
P1
1.68±0.06 2.19±0.10

<0.05

1.84±0.08

<0.05
>0.05

2.42±0.12

<0.05

2.12±0.12

<0.05
>0.05

MDA mcmol/l
P
P1
0.27±0.02 0.40±0.02

<0.05

0.30±0.03

>0.05
<0.05

0.46±0.05

<0.05

0.40±0.03

<0.05
>0.05

Activity of catalase, mlcat/l
P
P1
0.42±0.06 0.28±0.03

<0.05­

0.38±0.02

>0.05
>0.05

0.22±0.02

<0.05­

0.30±0.03

<0.05
<0.05

Activity of SOD, RU/l
P
P1
0.50±0.05 0.32±0.03

<0.05

0.40±0.06

>0.05
<0.05

0.28±0.03

<0.05

0.38±0.04

>0.05
<0.05

API 1.55 0.70 1.26 0.48 0.75
Urease­mccat/l
P
P1
0.050±0.006 0.140±0.04
<0.05­
0.087±0.03
<0.05
<0.05
0.154±0.04
<0.05­
0.120±0.04
<0.05
>0.05
Lysozyme, mcg/ml
P
P1
0.28±0.05 0.14±0.06

>0.05

0.26±0.04

>0.05
>0.05

0.16±0.03

>0.05

0.20±0.04

>0.05
>0.05

Level
of dysbiosis
0.17 1 0.33 0.96 0.60

Note: P — statistical significance with the control group; P1 — statistical significance with group “before treatment”.

Conclusion

In our study, we get the conclusions listed below. Local application in the combination therapy of the new hygienic agent on the basis of apiproducts positively affects on dynamics of clinical symptoms of the OM diseases, improving oral hygienic condition, rendering antiinflammatory and anaesthetic action; New apigel with OM diseases lowers level of inflammation and oral disbiosis, having an antimicrobial effect; Use of developed hygienic agent increases nonspecific reactivity in the oral cavity due to antioxidant defence enzymes activation; Obtained results prove gel application perspectiveness during treatment of the OM diseases for improvement of rehabilitation and quality of life of patients.

Competing interests

The authors declare that they have no competing interests.

Acknowledgments

None

References

1. Kravchenko L.S., Solodenko G.M. Gel dlya lіkuvannya reactsіy slyzovoi obolonky porozhnyny rota na promenevu terapіyu [Gel for treatment of oral mucosa in case of reactions for radiation therapy]. Patent of Ukraine №94885. Published 10.12.2014; 23: 4.

2. Golovko N.V., Babenko A.D. Evaluation of state of hygiene of oral cavity and parodontal tissues in patients suffering from chronic hypertrophic gingivitis agaist a background of treatment of non-removable technique. Ukrainskyy stomatologіchnyy almanakh 2010; 1: 8-10.

3. Levitskiy A.P., Makarenko O.A., Rossakhanova L.N. Salivation in healthy persons of different age and in dental patients. Vіsnyk stomatologіi: Spets. Vypusk 2005; 2: 7-8.

4. Barabash R.D., Levitskiy A.P. Casein-lytic and BAEE-esterase activity of saliva and salivary glands at rats in the postnatal ontogenesis. Bulleten eksperimentalnoi biologii 1973; 8: 65-67.

5. Stalnaya I.D., Garishvili T.G. Metod opredeleniya malonovogo dialdegida s pomoshchyu tiobarbiturovoi kisloty [Method of malonic dialdehyde detection with tiobarbituric acid]. Modern methods in biochemistry. Moscow, Medicine, 1977. p. 66-68.

6. Levitskiy A.P. Fermentativnyi metod opredeleniya disbioza polosti rta dlya skrininga proprebiotikov. Metodicheskiye rekomendatsii [Fermentation method of oral disbiosis detection for screening proprebiotics. Methodical recommendations]. Kiev, 2007. 20 p.

7. Korolyuk M.A., Ivanova D.I., Mayorova I.G. Method of catalase activity. Laboratornoye delo 1988; 1: 16-18.

8. Chevari S., Chaba I., Sekey I. Role of superoxide dismutase in oxidizing processes and method of its evaluation in biological material. Laboratornoye delo 1985; 11: 678-681.

9. Levitskiy A.P. Lizotsym vmesto antibiotikov [Lysozyme instead of antibiotics]. Odessa, KPOGT, 2005. 74 p.

Copyright

© This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/